activity
20202022
most citedPredicting conversion of mild cognitive impairment to Alzheimer's disease

6 citations · 8 across the 4 of their papers we have counts for

collaborators

7 papers

cs.CV2022

Multi-modal learning for predicting the genotype of glioma

Yiran Wei, Xi Chen, Lei Zhu +4

The isocitrate dehydrogenase (IDH) gene mutation is an essential biomarker for the diagnosis and prognosis of glioma. It is promising to better predict glioma genotype by integrati…

eess.IV20226 cited

Predicting conversion of mild cognitive impairment to Alzheimer's disease

Yiran Wei, Stephen J. Price, Carola-Bibiane Schönlieb +1

Alzheimer's disease (AD) is the most common age-related dementia. Mild cognitive impairment (MCI) is the early stage of cognitive decline before AD. It is crucial to predict the MC…

cs.LG20221 cited

Collaborative learning of images and geometrics for predicting isocitrate dehydrogenase status of glioma

Yiran Wei, Chao Li, Xi Chen +2

The isocitrate dehydrogenase (IDH) gene mutation status is an important biomarker for glioma patients. The gold standard of IDH mutation detection requires tumour tissue obtained v…

eess.IV20211 cited

Predicting isocitrate dehydrogenase mutation status in glioma using structural brain networks and graph neural networks

Yiran Wei, Yonghao Li, Xi Chen +3

Glioma is a common malignant brain tumor with distinct survival among patients. The isocitrate dehydrogenase (IDH) gene mutation provides critical diagnostic and prognostic value f…

cs.LG2021

Adaptive unsupervised learning with enhanced feature representation for intra-tumor partitioning and survival prediction for glioblastoma

Yifan Li, Chao Li, Yiran Wei +3

Glioblastoma is profoundly heterogeneous in regional microstructure and vasculature. Characterizing the spatial heterogeneity of glioblastoma could lead to more precise treatment.…

eess.IV2021

Expectation-Maximization Regularized Deep Learning for Weakly Supervised Tumor Segmentation for Glioblastoma

Chao Li, Wenjian Huang, Xi Chen +3

We present an Expectation-Maximization (EM) Regularized Deep Learning (EMReDL) model for weakly supervised tumor segmentation. The proposed framework is tailored to glioblastoma, a…